Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01.
By P. Eifel, K. Winter, M. Morris, C. Levenback, Perry Grigsby, J. Cooper, M. Rotman, D. Gershenson, David G. Mutch. Journal of Clinical Oncology, 2004
1,011 citations recorded by the source corpus.
Subfields: Obstetrics and Gynecology, Reproductive Medicine, Surgery
View Paper: https://www.semanticscholar.org/paper/b912ab9e931689e9a82a7a23ab32bb0f7a2bfba2
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- A. Viswanathan
- W. Small
- A. Jhingran
- A. Bajaj
- B. Fisher
- H. Kitchener
- L. Mileshkin
- M. Bacon
Citations in the corpus
- Cervical cancer: A global health crisis (2017, background): “52.(11) Consequently, this technique was rapidly adopted worldwide, and weekly cisplatin became the worldwide standard.”